Enhanced SARS-CoV-2 humoral immunity following breakthrough infection builds upon the preexisting memory B cell pool.
Saved in:
| Title: | Enhanced SARS-CoV-2 humoral immunity following breakthrough infection builds upon the preexisting memory B cell pool. |
|---|---|
| Authors: | Weber T; Institute of Virology, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany., Dähling S; Institute of Virology, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany., Rose S; Institute of Virology, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany., Affeldt P; Institute of Virology, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany.; Department II of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Vanshylla K; Institute of Virology, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany., Ullrich L; Institute of Virology, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany., Gieselmann L; Institute of Virology, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany., Teipel F; Institute of Virology, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany., Gruell H; Institute of Virology, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany., Di Cristanziano V; Institute of Virology, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany., Kim DS; Department of Biomedical Engineering, University of Texas at Austin, Austin, Texas, USA., Georgiou G; Department of Biomedical Engineering, University of Texas at Austin, Austin, Texas, USA.; Department of Chemical Engineering and Department of Molecular Biosciences and Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, Texas, USA.; Department of Oncology, University of Texas Dell Medical School, Austin, Texas, USA., Koch M; Institute for Dental Research and Oral Musculoskeletal Biology, Center for Biochemistry, Medical Faculty and University of Cologne, Cologne, Germany., Kreer C; Institute of Virology, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany., Klein F; Institute of Virology, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. |
| Source: | Science immunology [Sci Immunol] 2023 Nov 17; Vol. 8 (89), pp. eadk5845. Date of Electronic Publication: 2023 Nov 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101688624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2470-9468 (Electronic) Linking ISSN: 24709468 NLM ISO Abbreviation: Sci Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2470-9468 |
|---|---|
| DOI: | 10.1126/sciimmunol.adk5845 |
